Help | Scores |Exit
Fragmin | Magnex | Solu Medrol
Metoprolol Drug Name:  
A|B|C|D|E|F|G|H|I|K|L|M|N|O|P|Q|R|S|T|V|Z
Quick Dosage
Indications
Dosages
Interactions
Contraindications
Adverse Reactions
Precautions
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interactions:

Acarbose

  • Adverse Effect hypoglycemia, hyperglycemia, or hypertension
  • Clinical Management If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Adrenaline

  • Adverse Effect Hypertension, bradycardia, resistance to Adrenaline in anaphylaxis
  • Clinical Management Concurrent use should be avoided if possible. However, if used concurrently, monitor blood pressure carefully. If a nonselective Metoprolol causes resistance to Adrenaline in anaphylactic shock, glucagon may be effective in a dose of 1 mg or more intravenously every five minutes.

    Amiodarone

  • Adverse Effect hypotension, bradycardia, or cardiac arrest
  • Clinical Management Monitor cardiac function carefully. Amiodarone should be used with caution in patients receiving beta blockers particularly if there is suspicion of underlying dysfunction of the sinus node, such as bradycardia or sick sinus syndrome, or if there is partial AV block.

    Amlodipine

  • Adverse Effect hypotension and/or bradycardia
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Benidipine

  • Adverse Effect hypotension and/or bradycardia
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Celecoxib

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Chlorpropamide

  • Adverse Effect Hypoglycemia, hyperglycemia, or hypertension
  • Clinical Management If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Cimetidine

  • Adverse Effect Increased adverse effects of metoprolol (dizziness, insomnia, GI symptoms, postural hypotension)
  • Clinical Management Monitor patient response (blood pressure, pulse rate) to metoprolol when used concomitantly with cimetidine. Adjust metoprolol dosage as needed.

    Ciprofloxacin

  • Adverse Effect Bradycardia, hypotension
  • Clinical Management Monitor blood pressure and cardiac function with concurrent use. A metoprolol dosage adjustment may be required during ciprofloxacin therapy.

    Clonidine

  • Adverse Effect exaggerated clonidine withdrawal response (acute hypertension)
  • Clinical Management When clonidine is to be withdrawn from concomitant therapy with a beta blocker, discontinue the beta blocker first, and monitor blood pressure carefully. Labetalol (alph/beta blocker) or alpha blockers (eg, prazosin, doxazosin) may prevent rebound hypertension.

    Dextropropoxyphene

  • Adverse Effect an increased risk of hypotension and bradycardia
  • Clinical Management Monitor patients for an increased response to metoprolol.

    Diclofenac Preps

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Digoxin

  • Adverse Effect AV block and possible digoxin toxicity
  • Clinical Management When beta blockers and digoxin are to be given concomitantly, carefully monitor ECG and digoxin serum concentrations. Adjust doses accordingly.

    Diltiazem

  • Adverse Effect hypotension, bradycardia, AV conduction disturbances
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure. A dosage adjustment for hepatically metabolized beta blockers may be required.

    Diphenhydramine

  • Adverse Effect An increased risk of metoprolol toxicity (bradycardia, fatigue, bronchospasm)
  • Clinical Management Monitor patients for signs of metoprolol toxicity if diphenhydramine is added to the therapeutic regimen. The metoprolol dose may need to be adjusted when diphenhydramine is initiated or discontinued. This potential interaction should be noted especially since diphenhydramine is often self-administered without a physicians consent.

    Doxazosin

  • Adverse Effect an exaggerated hypotensive response to the first dose of the alpha blocker
  • Clinical Management When concurrent therapy with an alpha blocker and a beta blocker is required, initiate the alpha blocker with a smaller than usual dose, preferably at bedtime. Monitor the patient closely for hypotension.

    Felodipine

  • Adverse Effect hypotension and/or bradycardia
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Flunarizine

  • Adverse Effect hypotension, bradycardia, and AV conduction disturbances
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure or bradyarrhythmias.

    Fluoxetine

  • Adverse Effect An increased risk of metoprolol adverse effects (shortness of breath, bradycardia, hypotension, acute heart failure)
  • Clinical Management A water soluble beta blocker, such as atenolol, should be considered for fluoxetine-treated patients who require a beta blocker. If metoprolol and fluoxetine are coadministered, monitor patients for metoprolol adverse effects. A reduction in the metoprolol dose may be necessary.

    Flurbiprofen

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Glibenclamide

  • Adverse Effect hypoglycemia, hyperglycemia, or hypertension
  • Clinical Management If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects.Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Gliclazide

  • Adverse Effect hypoglycemia, hyperglycemia, or hypertension
  • Clinical Management If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Glimepiride

  • Adverse Effect hypoglycemia, hyperglycemia, or hypertension
  • Clinical Management If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Glipizide

  • Adverse Effect hypoglycemia, hyperglycemia, or hypertension
  • Clinical Management If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Guar Gum

  • Adverse Effect hypoglycemia, hyperglycemia, or hypertension
  • Clinical Management If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Hydralazine

  • Adverse Effect an increased risk of metoprolol adverse effects (bradycardia, fatigue, bronchospasm)
  • Clinical Management If concurrent therapy is required, take with food or switch to a sustained release beta blocker. Monitor blood pressure carefully.

    Ibuprofen

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Indomethacin

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Insulin Lispro

  • Adverse Effect hypoglycemia, hyperglycemia, or hypertension
  • Clinical Management If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Ketoprofen

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Ketorolac

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Lacidipine

  • Adverse Effect hypotension and/or bradycardia
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Lidoflazine

  • Adverse Effect hypotension, bradycardia, and AV conduction disturbances
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure or bradyarrhythmias.

    Lignocaine

  • Adverse Effect lidocaine toxicity (anxiety, myocardial depression, cardiac arrest)
  • Clinical Management With concurrent Metoprolol therapy, monitor lidocaine levels more closely (at least every 24 hours) and adjust lidocaine infusion rates appropriately.

    Mefenamic Acid

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Meloxicam

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Metformin

  • Adverse Effect hypoglycemia, hyperglycemia, or hypertension
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Methyldopa

  • Adverse Effect exaggerated hypertensive response, tachycardia, or arrhythmias during physiologic stress or exposure to exogenous catecholamines
  • Clinical Management Monitor blood pressure carefully during concurrent therapy, especially during excessive physiologic stress or use of exogenous catecholamines such as phenylpropanolamine.

    Nabumetone

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Naproxen

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Nifedipine

  • Adverse Effect hypotension and/or bradycardia
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Nimesulide

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Nimodipine

  • Adverse Effect hypotension and/or bradycardia
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Nitrendipine

  • Adverse Effect hypotension and/or bradycardia
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Oxyphenbutazone

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Paracetamol

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Phenacetin

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Phenobarbitone

  • Adverse Effect Decreased metoprolol effectiveness
  • Clinical Management If concurrent therapy is required, monitor for a reduction in the effectiveness of metoprolol. A dosage adjustment may be required. Timolol or atenolol may be an alternative beta-blocker choice because they are not dependent on first-pass hepatic metabolism.

    Phenylbutazone

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Piroxicam

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.
    Prazosin
  • Adverse Effect an exaggerated hypotensive response to the first dose of the alpha blocker
  • Clinical Management When concurrent therapy with an alpha blocker and a beta blocker is required, initiate the alpha blocker with a smaller than usual dose, preferably at bedtime. Monitor the patient closely for hypotension.
    Prazosin - BPH
  • Adverse Effect An exaggerated hypotensive response to the first dose of the alpha blocker
  • Clinical Management When concurrent therapy with an alpha blocker and a beta blocker is required, initiate the alpha blocker with a smaller than usual dose, preferably at bedtime. Monitor the patient closely for hypotension.

    Procainamide

  • Adverse Effect an increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest)
  • Clinical Management The concurrent administration of Procainamide is not recommended. The Procainamide should be withheld for at least three half-lives prior to dosing.

    Propafenone

  • Adverse Effect metoprolol toxicity (bradycardia, fatigue, shortness of breath)
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully, particularly blood pressure. A dosage adjustment for the Propafenone may be required.

    Quinidine

  • Adverse Effect Bradycardia, fatigue, shortness of breath
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully (ie, blood pressure, heart rate). A dosage adjustment may be required for both drugs.

    Rifampicin

  • Adverse Effect Decreased metoprolol effectiveness
  • Clinical Management If concurrent therapy is required, monitor blood pressure carefully. A dosage increase for metoprolol may be required.

    Ritodrine

  • Adverse Effect potential interference with tocolytic action of ritodrine
  • Clinical Management It is possible to successfully treat a patient with both a beta blocker and a beta mimetic if an appropriate dosage is found and the clinical response is monitored.

    Tenoxicam

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Terazosin

  • Adverse Effect an exaggerated hypotensive response to the first dose of the alpha blocker
  • Clinical Management When concurrent therapy with an alpha blocker and a beta blocker is required, initiate the alpha blocker with a smaller than usual dose, preferably at bedtime. Monitor the patient closely for hypotension.

    Terazosin - BPH

  • Adverse Effect An exaggerated hypotensive response to the first dose of the alpha blocker
  • Clinical Management When concurrent therapy with an alpha blocker and a beta blocker is required, initiate the alpha blocker with a smaller than usual dose, preferably at bedtime. Monitor the patient closely for hypotension.

    Tolbutamide

  • Adverse Effect hypoglycemia, hyperglycemia, or hypertension
  • Clinical Management If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Verapamil

  • Adverse Effect hypotension, bradycardia
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.
  • Magnex
    Magnesium Hydroxide (Milk of Magnesia)
    Magnesium Sulfate
    Mannitol
    Mebendazole
    Medroxyprogesterone Acetate
    Meperidine Hydrochloride (Pethidine Hydrochloride)
    Methocarbamol
    Methylprednisolone
    Metoclopramide Hydrochloride
    Metronidazole
    Midazolam Hydrochloride
    Minocycline Hydrochloride
    Montelukast Sodium
    Morphine Sulfate
    Medroxyprogesterone
    Mefenamic Acid
    Mefloquine
    Megesterol acetate
    Melatonin
    Meloxicam
    Melphalan
    Menadione
    Menapthone
    Meningitis Vaccine
    Menotrophin
    Measles Vaccine
    Mebeverine
    Mebeverine - Antispas
    Mepacrine
    Mephentermine
    Mercaptopurine
    Meclizine
    Mesalazine - Antisecr
    Mesna
    Mesterolone
    Metformin
    Methdilazine
    Methenamine
    Methotrexate
    Methoxsalen
    Methyl Cellulose
    Methyldopa
    Metoclopramide - Antispas
    Metoprolol
    Mexiletine
    Mg salts
    Mianserin
    Miconazole
    Miconazole - Ocular
    Miconazole - Topical
    Miconazole - VU
    Midazolam
    Mifepristone
    Minocycline
    Minoxidil
    Mirtazapine
    Misoprostol
    Mitomycin
    Mitoxantrone
    Mmr vaccine
    Moclobemide
    Molgramostim
    Mometasone
    Montelukast
    Mupirocin
    Mustine
     
    Disclaimer